Crossmark

Carbapenem susceptibilities of Gram-negative pathogens in intra-abdominal and urinary tract infections: updated report of SMART 2015 in China

Crossref DOI link: https://doi.org/10.1186/s12879-018-3405-1

Published Online: 2018-09-29

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhang, Hui

Kong, Haishen

Yu, Yunsong

Wu, Anhua

Duan, Qiong

Jiang, Xiaofeng

Zhang, Shufang

Sun, Ziyong

Ni, Yuxing

Wang, Weiping

Wang, Yong

Liao, Kang

Li, Huayin

Yang, Chunxia

Huang, Wenxiang

Gui, Bingdong

Shan, Bin

Badal, Robert

Yang, Qiwen

Xu, Yingchun http://orcid.org/0000-0002-9457-5635
Funding

Funding for this research was provided by:

Merck Sharp & Dohme

The National Key Research and Development Program of China (SQ2018YFC120102)

CAMS Innovation Fund for Medical Sciences (2016-I2M-1-014)

CAMS Initiative for Innovative Medicine (2016-I2M-3-014)
License Information

Text and Data Mining valid from 2018-09-29
More Information

Article History

Received: 3 May 2018

Accepted: 21 September 2018

First Online: 29 September 2018

Ethics approval and consent to participate

: The Human Research Ethics Committee of Peking Union Medical College Hospital approved this study and waived the need for consent (Ethics Approval Number: S-K238).

: Not applicable.

: Robert Badal received financial support in the form of salaries from International Health Management Associates, who receive funding from MSD to administer the SMART program and for SMART-related travel and consultation expenses.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.